comparemela.com

Latest Breaking News On - மில்டன் கீன்கள் பல்கலைக்கழகம் மருத்துவமனை - Page 7 : comparemela.com

Reporter challenges coroner over public 4-minute inquest

A news agency reporter who challenged a coroner when an inquest into the hanging of a young child was completed in less than four minutes was shocked when he was told the death “was not in the public interest”. James Llewelyn (pictured) was the only journalist present when Milton Keynes coroner Tom Osborne refused to give any details of the circumstances leading to the tragic accidental death of a 12-year-old boy who was found hanged at home. The hearing was attended only by Llewelyn, the coroner and coroner’s officer. No family of the boy turned up for the hearing.

The Ward Round: Is a mandatory covid jab for staff inevitable?

The Ward Round newsletter, by HSJ workforce correspondent Annabelle Collins, ensures you are tuned in to the daily pressures on staff, and the wider trends and policies shaping the workforce. Many readers of Earlier this month,  HSJ published an exclusive story revealing trust CEO Lesley Watts had written a letter addressed to the trust’s staff, which said the covid jab would be compulsory for all its employees and this would be written into employment contracts. However, just a few hours after our story went live, the trust denied there were plans to make the jab mandatory and said the letter had not actually been sent. This perhaps highlights how contentious the issue of a mandatory covid jab is.

UK trials set to re-expose people to virus

  Nurses treat a COVID-19 patient in the ICU (Intensive Care Unit) at Milton Keynes University Hospital, amid the spread of the coronavirus disease (COVID-19) pandemic, Milton Keynes, Britain, Jan 20, 2021. [Photo/Agencies] Move to better understand immune system reaction, help design vaccines People who have recovered from COVID-19 disease will be deliberately re-exposed to the novel coronavirus that causes it in medical trials that start this week in the United Kingdom. The so-called challenge trials, which are being led by the University of Oxford, will look at how much protection people have against reinfection, and against developing the disease for a second time.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.